CYRX
Cryoport, Inc.
NASDAQ · Industrials · Integrated Freight & Logistics · US
$16.73
+1.71%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$16.69
From 52W high−10.24%
Volume80085.00
Market cap$847.40M
P/E (TTM)—
P/S (TTM)4.5x
Div yield—
Key dataNov 4, 2026
Open
$16.69
From 52W high
−10.24%
Volume
80085.00
Market cap
$847.40M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−233.0x
P/E (TTM)
—
RSI (14)
43.4
MomentumView details →
1D Return
+1.71%
YTD Return
+72.50%
SummaryUpdated Jun 1, 2026
Cryoport, Inc. (NASDAQ:CYRX) is a Tennessee-based life sciences services company founded in 1999 that specializes in temperature-controlled logistics solutions for the biotechnology and pharmaceutical industries. The company went public in 2005 and has evolved from a niche cryogenic shipping provider into a comprehensive logistics platform serving the rapidly growing cell and gene therapy market. Today, Cryoport operates globally across the Americas, Europe, the Middle East, Africa, and Asia Pacific, supporting over 675 clinical trials and 14 commercial therapies through its integrated suite of logistics services and cryogenic systems.
Similar companies
Latest newsMore news →
Cryoport announced that it will report financial results for the third quarter ended September 30, 2026, on November 5, 2026, after U.S. markets close.13d agoCryoport reported its second quarter 2026 financial results, with revenue growing 8% year-over-year to $49.0 million and Life Sciences Services revenue up 15%, BioStorage/BioServices revenue up 25%, supporting 779 global clinical trials and 22 commercially approved cell and gene therapies as of June 30, 2026.90d ago